ARCA BIOPHARMA, INC.

WESTMINSTER, CO How do I update this listing?

Arca Biopharma is based out of Westminster. Arca Biopharma discovers, develops and commercializes novel products for acute cardiovascular indications and cancer. As of March 2005, the company had three drug candidates in clinical trials, including its lead candidate, alfimeprase, a thrombolytic agent.Whalewisdom has at least 116 Form 4 filings The firm last filed a Form D notice of exempt offering of securities on 2015-06-25. The notice included securities offered of Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security

Create Alert

Contact Info

arca biopharma, inc.
10170 CHURCH RANCH WAY
WESTMINSTER CO    80021

Business Phone: 7209402200
SEC SIC CODE:
2835-IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES

Active Schedule 13D and 13G events

Sign in to see

Insider Transactions in the past year

Loading...

Form D Filings

Form D is a form to be used to file a notice of an exempt offering of securities with the Securities and Exchange Commission. Form D contains basic information about the offering and the company.

Form D Filings
Filing Date Form Type Industry Group Securities Offered Total Offering Amount Total Amount Sold Total Remaining
2015-06-25 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 51,650,404 51,650,404 0
2014-02-20 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 326,158 326,158 0
2013-06-17 D PHARMACEUTICALS Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 1,250,000 1,250,000 0
2013-02-01 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 1,000,000 1,000,000 0
2012-12-28 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 250,000 250,000 0
2012-10-31 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 325,000 325,000 0
2012-01-05 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 4,549,285 4,549,285 0
2009-10-26 D PHARMACEUTICALS Equity,Option, Warrant or Other Right to Acquire Another Security,Security to be Acquired Upon Exercise of Option, Warrant or Other Right to Acquire Security 499,999 499,999 0
Other Issuers in Filings
Name Address
No Other Issuers
Related Parties included in filings
Name Address Relationship
BRIAN L. SELBY subscription required
    EXECUTIVE OFFICER
BURTON E. SOBEL subscription required
    DIRECTOR
CHRISTOPHER D. OZEROFF subscription required
    EXECUTIVE OFFICER
DAN J. MITCHELL subscription required
    DIRECTOR
J. WILLIAM FREYTAG subscription required
    DIRECTOR
JEAN-FRANCOIS FORMELA subscription required
    DIRECTOR
JOHN L. ZABRISKIE subscription required
    DIRECTOR
KATHRYN E. FALBERG subscription required
    EXECUTIVE OFFICER
LINDA GRAIS subscription required
    DIRECTOR
MARY K. PENDERGAST subscription required
    DIRECTOR
MICHAEL R. BRISTOW subscription required
    EXECUTIVE OFFICER DIRECTOR
PATRICK M. WHEELER subscription required
    EXECUTIVE OFFICER
RAYMOND L. WOOSLEY subscription required
    DIRECTOR
RICHARD B. BREWER subscription required
    DIRECTOR
ROBERT E. CONWAY subscription required
    DIRECTOR
TED W. LOVE subscription required
    DIRECTOR
THOMAS A. KEUER subscription required
    EXECUTIVE OFFICER

Elevate your investments